Skip to main content
Premium Trial:

Request an Annual Quote

CuraGen Offers Additional $10M of Convertible Subordinated Notes

NEW YORK, March 17 (GenomeWeb News) - CuraGen has added $10 million of convertible subordinated notes to its initial offer of $100 million, the company said today.


CuraGen issued the notes as a 30-day option to initial buyers of the notes to cover over-allotments. In total, CuraGen has now sold $110 million aggregate principal amount of notes, which are due in 2011, at an interest rate of 4 percent.


Last month, CuraGen said that it would issue $75 million of notes.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.